Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - MABVAX THERAPEUTICS HOLDINGS, INC. | mbvxs1a_jan2018.htm |
| EX-5.1 - OPINION ON LEGALITY - MABVAX THERAPEUTICS HOLDINGS, INC. | ex5-1.htm |
Exhibit
23.1
Consent of
Independent Registered Public Accounting Firm
We consent to the
inclusion in this Amendment No. 1 to the registration
statement on Form S- 1 (333-222069) of MabVax
Therapeutics Holdings, Inc., of our report dated March 1, 2017,
related to our audit of the consolidated financial statements of
MabVax Therapeutics Holdings, Inc., as of December 31, 2016 and
2015 and for the years then ended, which report included an
explanatory paragraph relating to MabVax Therapeutics, Inc.’s
ability to continue as a going concern. We also consent to the
reference to our Firm under the caption
“Experts”.
/s/
CohnReznick LLP
San Diego,
California
January
12, 2018